An observational cohort study in Zhejiang, China, has seen many asymptomatic children with the novel coronavirus disease (COVID-19), demonstrating the difficulty in isolating paediatric patients who do not have clear epidemiological information. In addition, this poses a serious situation in community-acquired infections.
It takes just less than 4 days for COVID-19 to spread from one person to another and cause symptoms, and more than 10 percent of the cases are infected by a person who has caught the virus but yet to show symptoms, recent studies suggest.
A deep learning-based artificial intelligence (AI) boasts accurate detection of COVID-19 and distinguishes it from community-acquired pneumonia (CAP) and other lung diseases, as shown in a recent study.
Urogenital infections remain a major reason for women to visit their family physician and their subsequent referral to obstetrics and gynaecology or urology specialists. The association between abnormal vaginal microbiota and an increased risk of contracting sexually transmitted diseases (STDs), as well as an increased rate of preterm labour, indicates the need to better understand and manage urogenital health in women. Probiotics are “live microorganisms which, when administered in adequate amounts, confer a health benefit on the host”. As such, there is a sound rationale for using probiotics to maintain female vaginal and bladder health.
The angiotensin receptor blocker (ARB) losartan did not improve inflammation, T-cell immune recovery, or fibrotic activity among older persons living with HIV (PLHIV) and viral suppression, according to data presented at CROI 2020.